PACT Pharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors (NCT03970382) | PACT Pharma, Inc. | 2019-07-03 |
Track PACT Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.